pioglitazone has been researched along with Bronchitis in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Bronchitis: Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hetzel, M | 1 |
| Walcher, D | 1 |
| Grüb, M | 1 |
| Bach, H | 1 |
| Hombach, V | 1 |
| Marx, N | 1 |
1 other study available for pioglitazone and Bronchitis
| Article | Year |
|---|---|
Inhibition of MMP-9 expression by PPARgamma activators in human bronchial epithelial cells.
Topics: Blotting, Northern; Bronchi; Bronchitis; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Epithel | 2003 |